New drug development in the United States from 1963 to 1999

被引：142

作者：

DiMasi, JA ^{[1
]}

机构：

[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA

来源：

关键词：

D O I：

10.1067/mcp.2001.115132

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：286 / 296

页数：11

共 25 条

[1] *ASS DIR NEW DRUG, 1976, DRUG CLASS STAFF MAN
[2] DiMasi J.A., 1997, DRUG INFORM J DIJDRU, V31, P771
[3] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992
DIMASI, JA
SEIBRING, MA
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) : 609 - 622
[4] SUCCESS RATES FOR NEW DRUGS ENTERING CLINICAL-TESTING IN THE UNITED-STATES
DIMASI, JA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) : 1 - 14
[5] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY
DIMASI, JA
HANSEN, RW
GRABOWSKI, HG
LASAGNA, L
[J]. JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) : 107 - 142
[6] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990
DIMASI, JA
BRYANT, NR
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) : 471 - 486
[7] DiMasi JA, 2000, DRUG INF J, V34, P1169, DOI 10.1177/009286150003400425
[8] DiMasi JA., 1995, INT J ECON BUS, V2, P201, DOI [10.1080/758519309, DOI 10.1080/758519309]
[9] Drews J., 1996, DRUG INF J, V30, P97
[10] Drews J, 1999, QUEST TOMORROWS MED